Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways

• Main Authors: Mi Zhou (Author), Ling Meng (Author), Qinke He (Author), Chunguang Ren (Author), Changyi Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. Valsartan, an angiotensin II type 1 receptor antagonist, is clinically used to treat hypertension and has an...